AMLN Amylin Pharmaceuticals, Inc. (MM)

Amylin Pharmaceuticals to Webcast Third Quarter Company Update Conference Call SAN DIEGO, Oct. 30 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. plans to webcast its Quarterly Update Conference Call for the third quarter of 2003 on Tuesday, November 4, 2003 at 12:00 p.m. Eastern/9:00 a.m. Pacific. The call will be led by Ginger L. Graham, Amylin's President and Chief Executive Officer. The Company will release financial results for the third quarter that morning before the market opens. The call will be webcast live through Amylin's corporate website and a recording will be made available following the close of the call. To access the webcast, please log on to http://www.amylin.com/ approximately fifteen minutes prior to the call to register, download and install any necessary audio software. A recording will be available by phone for 24 hours beginning approximately one hour after the close of the call and can be accessed at 888-286-8010 (domestic) or 617-801-6888 (international), passcode 25873740. Amylin Pharmaceuticals is engaged in the discovery, development and commercialization of potential drug candidates for the treatment of diabetes and other metabolic diseases. DATASOURCE: Amylin Pharmaceuticals, Inc. CONTACT: Mark G. Foletta, Vice President of Finance and Chief Financial Officer of Amylin Pharmaceuticals, Inc., +1-858-552-2200 Web site: http://www.amylin.com/

Copyright